LuciCapma (Capmatinib) in London, Washington USA, Canberra Australia, Singapore and Manila Philippines

LuciMob is used for treating EGFR exon 20 insertion mutation-positive lung cancer. Active Ingredient Mobocertinib targets EGFR exon 20 mutations. Uses of LuciMob • EGFR exon 20 NSCLC How LuciMob Works Inhibits abnormal EGFR signaling pathways. How to Use LuciMob • Take as prescribed Possible Side Effects • Diarrhea • Rash Precautions • Monitor heart rhythm Safety Information Requires medical supervision. Storage • Store at room temperature • Keep away from moisture • Keep out of reach of children

LuciLorla is used in advanced ALK-positive lung cancer, especially after other treatments fail. Active Ingredient Lorlatinib is a third-generation ALK inhibitor. Uses of LuciLorla • ALK-positive NSCLC How LuciLorla Works Blocks ALK mutations and resistance pathways. How to Use LuciLorla • Take once daily Possible Side Effects • Weight gain • Mood changes Precautions • Monitor cholesterol Safety Information Use under supervision. Storage • Store at room temperature • Keep away from moisture • Keep out of reach of children

LuciAvat is used to increase platelet counts in patients with thrombocytopenia. Active Ingredient Avatrombopag stimulates platelet production. Uses of LuciAvat • Chronic liver disease thrombocytopenia How LuciAvat Works Activates thrombopoietin receptors to increase platelets. How to Use LuciAvat • Take as directed Possible Side Effects • Headache • Fatigue Precautions • Monitor platelet count Safety Information Doctor supervision required. Storage • Store at room temperature • Keep away from moisture • Keep out of reach of children